sesamol has been researched along with Disease Models, Animal in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (10.00) | 29.6817 |
2010's | 11 (55.00) | 24.3611 |
2020's | 7 (35.00) | 2.80 |
Authors | Studies |
---|---|
Gao, JM; Li, L; Liu, Q; Liu, X; Liu, Z; Mo, F; Xi, Y; Xie, T; Yuan, T | 1 |
Bo, X; Kou, R; Li, X; Liu, Q; Liu, X; Shi, R; Wang, D; Wang, Y; Xia, B; Ye, J; Zhang, L; Zhao, B | 1 |
Chen, JH; Lin, C; Qin, H; Shi, XQ; Xu, HY; Yang, LN; Yu, L | 1 |
Chang, SH; Lee, DH; Park, KW; Song, NJ; Yang, DK; Yun, UJ | 1 |
Kou, R; Li, X; Liu, X; Liu, Z; Shi, R; Xia, B; Zhang, L; Zhao, B | 1 |
Bhaskaran, NA; Gourishetti, K; Jitta, SR; Keni, R; Krishnadas, N; Kumar, L; Kumar, N; Nayak, PG; Shenoy, RR | 1 |
Cao, J; Wang, H; Wang, Y; Zhang, P | 1 |
Atyabi, F; Azhdarzadeh, M; Dehpour, AR; Dinarvand, M; Dinarvand, R; Hassanzadeh, P | 1 |
Hiraali, MC; Kaya, H; Pekel, G; Şahin, B; Yörükoğlu, A | 1 |
Ambasta, RK; Anand, K; Kumar, P; Sarkar, A; Sonia Angeline, M | 1 |
Chua, MD; Huber, JD; Kelly, KA; Ptachcinski, RL; VanGilder, RL | 1 |
Kalonia, H; Kumar, A; Kumar, P | 1 |
Arora, V; Chopra, K; Kuhad, A; Tiwari, V | 1 |
Chopra, K; Kuhad, A; Kumar, B | 1 |
Desikan, R; Kampfrath, T; Kherada, N; Mihai, G; Parthasarathy, S; Rajagopalan, S; Selvendiran, K; Simonetti, O; Sun, Q; Ying, Z; Ziouzenkova, O | 1 |
Chou, YC; Duann, YF; Hsiao, G; Hsieh, CY; Jayakumar, T; Lu, YC; Sheu, JR; Yu, SY | 1 |
Hyodo, K; Katsuta, M; Kinugasa, C; Naemura, A; Nakai, Y; Yamamoto, J | 1 |
Chu, PY; Deng, JF; Liu, MY; Srinivasan, P | 1 |
Pugalendi, KV; Vennila, L | 1 |
Chien, SP; Chu, PY; Chuang, YC; Hsu, DZ; Li, YH; Liu, MY | 1 |
20 other study(ies) available for sesamol and Disease Models, Animal
Article | Year |
---|---|
Sesamol Attenuates Amyloid Peptide Accumulation and Cognitive Deficits in APP/PS1 Mice: The Mediating Role of the Gut-Brain Axis.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Benzodioxoles; Brain; Cognition; Cognitive Dysfunction; Disease Models, Animal; Mice; Mice, Transgenic; Neurodegenerative Diseases; Peptides; Phenols | 2021 |
Sesamol ameliorates dextran sulfate sodium-induced depression-like and anxiety-like behaviors in colitis mice: the potential involvement of the gut-brain axis.
Topics: Animals; Antioxidants; Anxiety Disorders; Behavior, Animal; Benzodioxoles; Brain-Gut Axis; Colitis; Dextran Sulfate; Dietary Supplements; Disease Models, Animal; Male; Maze Learning; Mice; Mice, Inbred C57BL; Phenols; Plant Extracts | 2022 |
Sesamol Alleviates Obesity-Related Hepatic Steatosis via Activating Hepatic PKA Pathway.
Topics: Adiposity; Animals; Benzodioxoles; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Enzyme Activation; Fatty Liver; Hep G2 Cells; Hepatocytes; Humans; Lipid Metabolism; Liver; Male; Mice, Inbred C57BL; Obesity; Phenols; Phosphorylation; Signal Transduction; Weight Gain | 2020 |
Sesamol Increases Ucp1 Expression in White Adipose Tissues and Stimulates Energy Expenditure in High-Fat Diet-Fed Obese Mice.
Topics: Adipocytes; Adipose Tissue, White; Animals; Benzodioxoles; Cell Culture Techniques; Diet, High-Fat; Disease Models, Animal; Energy Metabolism; Mice; Mice, Obese; Obesity; Phenols; Uncoupling Protein 1; Weight Gain | 2020 |
Sesamol Supplementation Attenuates DSS-Induced Colitis via Mediating Gut Barrier Integrity, Inflammatory Responses, and Reshaping Gut Microbiome.
Topics: Animals; Bacteria; Benzodioxoles; Colitis; Dextran Sulfate; Dietary Supplements; Disease Models, Animal; Fatty Acids, Volatile; Gastrointestinal Microbiome; Humans; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Phenols; Tight Junction Proteins | 2020 |
Sesamol-Loaded PLGA Nanosuspension for Accelerating Wound Healing in Diabetic Foot Ulcer in Rats.
Topics: Animals; Benzodioxoles; Blood Glucose; Body Weight; Calorimetry, Differential Scanning; Diabetes Mellitus, Experimental; Diabetic Foot; Diet, High-Fat; Disease Models, Animal; Drug Liberation; Extracellular Signal-Regulated MAP Kinases; Glucose Tolerance Test; HSP27 Heat-Shock Proteins; Male; Nanoparticles; Neovascularization, Physiologic; Phenols; Platelet-Derived Growth Factor; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Rats, Wistar; Spectroscopy, Fourier Transform Infrared; Streptozocin; Suspensions; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Wound Healing | 2020 |
Sesamol alleviates chronic intermittent hypoxia-induced cognitive deficits via inhibiting oxidative stress and inflammation in rats.
Topics: Animals; Antioxidants; Benzodioxoles; Cognition; Cognitive Dysfunction; Disease Models, Animal; Hypoxia; Inflammation; Interleukin-1beta; Morris Water Maze Test; Oxidative Stress; Phenols; Rats; Sleep Apnea, Obstructive; Tumor Necrosis Factor-alpha | 2021 |
Application of nanostructured lipid carriers: the prolonged protective effects for sesamol in in vitro and in vivo models of ischemic stroke via activation of PI3K signalling pathway.
Topics: Animals; Antioxidants; Benzodioxoles; Brain Ischemia; Cell Survival; Disease Models, Animal; Lipids; Male; Nanostructures; Particle Size; PC12 Cells; Phenols; Phosphatidylinositol 3-Kinases; Rats; Signal Transduction; Stroke | 2017 |
Is Sesamol Effective in Corneal Neovascularization?
Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Antioxidants; Benzodioxoles; Bevacizumab; Corneal Neovascularization; Disease Models, Animal; Drug Therapy, Combination; Injections, Intraocular; Phenols; Rats; Rats, Wistar | 2018 |
Sesamol and naringenin reverse the effect of rotenone-induced PD rat model.
Topics: Animals; Benzodioxoles; Disease Models, Animal; Flavanones; Male; Parkinson Disease, Secondary; Phenols; Rats; Rats, Wistar; Rotenone | 2013 |
Administration of sesamol improved blood-brain barrier function in streptozotocin-induced diabetic rats.
Topics: Analysis of Variance; Animals; Antioxidants; Benzodioxoles; Blood Glucose; Blood-Brain Barrier; Brain; Capillary Permeability; Catalase; Claudin-5; Diabetes Mellitus, Experimental; Disease Models, Animal; Ethidium; Gene Expression Regulation; Male; Membrane Proteins; Microscopy, Confocal; Oxidative Stress; Peroxynitrous Acid; Phenols; Phosphoproteins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Spectrophotometry; Streptozocin; Zonula Occludens-1 Protein | 2009 |
Protective effect of sesamol against 3-nitropropionic acid-induced cognitive dysfunction and altered glutathione redox balance in rats.
Topics: Animals; Behavior, Animal; Benzodioxoles; Cognition Disorders; Disease Models, Animal; Escape Reaction; Free Radical Scavengers; Glutathione; Male; Maze Learning; Memory; Neurotoxins; Nitro Compounds; Oxidative Stress; Oxidoreductases; Phenols; Plants, Medicinal; Propionates; Rats; Rats, Wistar; Sesamum | 2010 |
Sesamol suppresses neuro-inflammatory cascade in experimental model of diabetic neuropathy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzodioxoles; Diabetic Neuropathies; Disease Models, Animal; Inflammation; Inflammation Mediators; Male; Neurons; Phenols; Rats; Rats, Wistar; Signal Transduction | 2010 |
Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Benzodioxoles; Brain; Chronic Disease; Depression; Disease Models, Animal; Food Preferences; Lipid Peroxidation; Male; Mice; Mice, Inbred Strains; Motor Activity; Phenols; Psychopharmacology; Stress, Psychological | 2011 |
A modified sesamol derivative inhibits progression of atherosclerosis.
Topics: Animals; Aorta; Aortic Diseases; Atherosclerosis; Benzodioxoles; Cardiovascular Agents; Cattle; Cell Adhesion Molecules; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Gene Expression Regulation; Hyperlipidemias; I-kappa B Kinase; I-kappa B Proteins; Magnetic Resonance Imaging; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Oxidative Stress; Phenols; Phosphorylation; Rabbits; Time Factors; Transfection; Vasoconstriction; Vasodilation | 2011 |
Chondroprotective role of sesamol by inhibiting MMPs expression via retaining NF-κB signaling in activated SW1353 cells.
Topics: Animals; Benzodioxoles; Cell Line, Tumor; Chondrocytes; Disease Models, Animal; Down-Regulation; Gene Expression Regulation, Enzymologic; Humans; Male; Matrix Metalloproteinases; NF-kappa B; Osteoarthritis; Phenols; Protective Agents; Rats; Rats, Wistar; Signal Transduction | 2011 |
Experimental antithrombotic effects of sesame seed whole grains and extracts.
Topics: Administration, Oral; Animals; Benzodioxoles; Diet, High-Fat; Dioxoles; Disease Models, Animal; Edible Grain; Fibrinolytic Agents; Humans; Infusions, Intra-Arterial; Lasers; Lignans; Male; Mice; Mice, Inbred C57BL; Phenols; Plant Extracts; Sesamum; Thrombosis | 2011 |
Sesamol attenuates oxidative stress-mediated experimental acute pancreatitis in rats.
Topics: Acute Disease; Amylases; Animals; Antioxidants; Benzodioxoles; Cell Line, Tumor; Cell Survival; Ceruletide; Disease Models, Animal; Dose-Response Relationship, Drug; Lipid Peroxidation; Male; Mice; Oxidative Stress; Pancreatitis; Phenols; Rats; Rats, Wistar | 2012 |
Efficacy of sesamol on plasma and tissue lipids in isoproterenol-induced cardiotoxicity in Wistar rats.
Topics: Animals; Antioxidants; Benzodioxoles; Disease Models, Animal; Dose-Response Relationship, Drug; Hypolipidemic Agents; Isoproterenol; Lipid Metabolism; Lipids; Male; Myocardial Infarction; Phenols; Rats; Rats, Wistar | 2012 |
Attenuation of endotoxin-induced oxidative stress and multiple organ injury by 3,4-Methylenedioxyphenol in rats.
Topics: Animals; Antioxidants; Benzodioxoles; Disease Models, Animal; Endotoxins; Kidney; Lipopolysaccharides; Liver; Male; Multiple Organ Failure; Nitrites; Oxidative Stress; Phenols; Rats; Rats, Wistar | 2006 |